학술논문
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study
Document Type
Article
Author
Meric-Bernstam, Funda ; Beeram, Muralidhar; Hamilton, Erika; Oh, Do-Youn; Hanna, Diana L; Kang, Yoon-Koo; Elimova, Elena; Chaves, Jorge; Goodwin, Rachel; Lee, Jeeyun; Nabell, Lisle; Rha, Sun Young; Mayordomo, Jose; El-Khoueiry, Anthony; Pant, Shubham; Raghav, Kanwal; Kim, Jin Won; Patnaik, Amita; Gray, Todd; Davies, Rupert; Ozog, Mark A; Woolery, Joseph; Lee, Keun-Wook
Source
In The Lancet Oncology December 2022 23(12):1558-1570
Subject
Language
ISSN
1470-2045